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Background: Mesenchymal stem cells (MSCs) have been reported to play an important role in tumor growth.
Inflammation is an important feature of hepatocellular carcinoma (HCC). Certain inflammatory cytokines produced
in tumor microenvironment modulate functional activities of MSCs. At the present time, however, the role of MSCs
in the development of HCC cell resistance to chemotherapy in the inflammatory microenvironment during tumor
growth has not yet been identified.
Methods: MTT and PI/Annexin V-FITC assay were employed to examine the proliferation and apoptosis of HCC cell
lines. The expression of TGF-β are detected by Realtime PCR and Western blot. GFP tagged LC3 expression vector
and electron microscopy are utilized to demonstrate the occurrence of autophagy.
Results: We observed that MSCs pretreated with the combination of IFN-γ and TNF-α induced resistance to
chemotherapy in HCC cell lines in both the in vitro and in vivo circumstances. Following exposure to conditioned
medium of MSCs that were pre-treated with IFN-γ plus TNF-α, HCC cell line cells underwent autophagy which
serves as a protective mechanism for HCC cells to resist the cell toxicity of chemotherapeutic agents. Treatment of
HCC cell line cells with autophagy inhibitor effectively reversed the MSCs-induced resistance to chemotherapy in
these cells. Stimulation with the combination of IFN-γ and TNF-α provoked expression of TGF-β by MSCs.
MSCs-induced chemoresistance in HCC cell lines was correlated with the up-regulation of TGF-β expression by
MSCs. Knockdown of TGF-β expression by MSCs with siRNA attenuated MSCs-induced chemoresistance in HCC cells.
Conclusions: These results suggest that increase in TGF-β expression by MSCs in the inflammatory microenvironment
of HCC promotes the development of chemoresistance in HCC cells.
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Chemotherapy remains a major treatment alternatively to
surgery for a large number of patients at the advanced stage
of hepatocellular carcinoma (HCC). However, development
of chemoresistance in HCC cells becomes a prominent
obstacle for effective treatment of HCC with chemotherapy.* Correspondence: lixinwei@smmu.edu.cn
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unless otherwise stated.In addition to the chemoresistance originated from HCC
cells themselves, accumulated evidences suggest that tumor
microenvironment may also play an important role in indu-
cing and/or promoting the development of drug resistance.
Studies have shown that existence of certain specific prop-
erties of stromal cells is an indicator for poor prognosis [1].
Stromal cells may modulate the reaction of tumor cells to
chemotherapy in various ways [2-5].
Mesenchymal stem cells (MSCs) have caught a wide
attention in recent years because of their therapeutic po-
tential to treat human diseases and their physiological. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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marrow, but they have also been isolated from other sites
in the body such as adipose tissue and uterus [8]. MSCs
have the ability to differentiate into cells of multiple line-
ages including chondrocytes, osteocytes, adipocytes, myo-
cytes, and astrocytes [9,10]. MSCs is positive for CD29,
CD90 and CD105 and is negative for hematopoietic cell
markers CD34 and CD45 [11]. MSCs express the major
histocompatibility complex (MHC) class I but do not ex-
press MHC class II, B7-1, B7-2, CD40, or CD40L mole-
cules. They can be expanded more than 104-fold in
culture without losing multilineage differentiation poten-
tial [12]. Therefore, MSCs are not only considered as an
acceptable source of stem cells in hematopoietic recovery,
but also an available cell type for tissue regeneration [9].
Interestingly, MSCs have the ability to migrate to tumor
sites in different types of tumor models [13-15]. Inflamma-
tion is a common feature of the tumor microenvironment
[16], which consists of cytokines, chemokines, and infil-
trated leukocytes. MSCs may secrete several different
types of mediators including interleukin-10 (IL-10) [17],
transforming growth factor-β (TGF-β) [17,18], hepatocyte
growth factor (HGF) [18], and vascular endothelial growth
factor (VEGF) [19] when exposed to inflammatory cyto-
kines, which has been reported to play an important role
in tumor development.
In previous studies, we have demonstrated that MSCs in
inflammatory environment may promote tumor growth
via immunosuppression and angiogenesis. However, the
role of MSCs in the development of chemoresistance in
HCC cells in the inflammatory microenvironment during
tumor growth remains unclear. The purpose of this study
is to investigate the contribution of MSCs to development




Recombinant human IFN-γ (Cat. 300-02B) and TNF-α
(Cat. 300-01A) were obtained from Peprotech (La Jolla,
CA). Stock solutions of chemotherapeutic agents cisplatin
(Qilu Pharmaceutical Co., Ltd., Jinan, Shandong, China,
Cat.H20073653) and epirubicin (Pfizer Pharmaceuticals
Limited, Wuxi, Jiangsu, China, Cat.H20093251) were pre-
pared at the concentration of 1 mM, respectively. The stock
solution of each agent was then added directly into cell cul-
ture media to achieve final concentrations as indicated in
each figure legend in the “Results” section. Chloroquine
(CQ, Cat.C6628) and 3-methyladenine (3-MA, Cat.M9281)
were purchased from Sigma-Aldrich (St. Louis, MO).
Culture of cell line cells
Human MSCs (a gift from Institute of Health Sciences
and Shanghai Institute of Immunology, Chinese Academyof Sciences, Shanghai, China) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) nutrient mix F12 with
fetal bovine serum (FBS, 10%; Invitrogen, Cat. 10099-054).
HCC cell line cells including SMMC-7721 cells and Hep-
G2 cells were cultured in DMEM containing 10% FBS. All
cells were cultured at 37°C in a humidified atmosphere
containing 5% CO2.
Generation of conditioned medium
MSCs were stimulated with IFN-γ (20 ng/ml), TNF-α
(20 ng/ml) or both for 12 h. The culture medium of
MSCs was removed. Stimulated MSCs were cultured in
fresh DMEM nutrient mix F12 for 24 h. The condi-
tioned medium in the MSC culture was then collected
and filtered through a 0.22 μm filter.
Real-time RT-PCR
MSCs were cultured with IFN-γ (20 ng/ml), TNF-α
(20 ng/ml), or both for 12 h. The cells were collected.
Total mRNA was extracted from cells using the Trizol
Reagent (Invitrogen, Carlsbad, CA, Cat.15596-026) and
protocol provided by the manufacturer. Expression of
TGF-β mRNA was determined by real-time RT-PCR using
the SYBR Green Master Mix Kit (Applied Biosystems,
Foster City, CA, Cat.4306736) and protocol provided by
the manufacturer. The amount of endogenous β-actin
mRNA was used for normalization of TGF-β mRNA
expression in each sample. Primers for TGF-β mRNA de-
termination were: 5′-GCCGAGCCCTGGACACCAAC-3′
(forward) and 5′-GCGCCCGGGTTATGCTGGTT-3′ (re-
verse). Thermocycler conditions included an initial hold at
50°C for 2 minutes and then 95°C for 10 minutes, which
was followed by a two-step PCR program of 95°C for
15 seconds and 60°C for 60 seconds repeated for 40 cycles
on a Mx4000 system (Stratagene). Alteration of TGF-β
mRNA expression is presented as the fold change relative
to an untreated control.
MTT colorimetric assay
To measure the effects of MSCs on chemosensitivity of
human hepatoma cells, HCC cells were seeded in 96-
well plates at a density of 1 × 104 cells/well and cultured
in the medium containing chemotherapeutic agents with
or without MSCs conditioned medium for 8 h. The cell
viability in each well was examined by a MTT (5 mg/ml,
Sigma-Aldrich, Cat.M2003) colorimetric assay. The op-
tical density (OD) value at 490 nm of each sample was
measured using a plate reader. All determinations were
carried out in sextuplicate.
Cell apoptosis assay
HCC cells (2 × 105cells/well) were cultured in 6-well
plates to 70–80% confluence. The cells were then treated
with chemotherapeutic agents for 8 h in the absence and
Table 1 Sequence of the oligonucleotides for siRNA
construct-making assays
Assays Gene Sequence (5′→ 3′)
TGFβ1 siRNA
Sequence 1 Sense CACUGCAAGUGGACAUCAATT
Antisense UUGAUGUCCACUUGCAGUGTT
Sequence 2 Sense GCAAGACUAUCGACAUGGATT
Antisense UCCAUGUCGAUAGUCUUGCTT
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periments, 3-MA (5 mM) was used to block autophagy.
PI/Annexin V-FITC assay was used to measure apoptotic
cells by flow cytometry according to the manufacturer’s
instruction (Keygen Biotech. Co., Ltd, Nanjing, Jiangsu,
China, Cat.KGA108). Briefly, cells collected by trypsiniza-
tion were washed trice with ice cold phosphate-buffered
saline (PBS). Cells were then incubated in 300 μL of 1×
binding buffer containing 5 μL Annexin V and 5 μL PI for
30 min at room temperature in the dark. Apoptosis of
cells was measured on a BD FACSAria flow cytometer
(Becton Dickinson, Lincoln Park, NJ). At least 30,000
gated events were acquired from each sample. Results are
expressed as the percentage of apoptotic cells (PI and
Annexin V positive) in the gated cell population.
Transient transfection and identification of autophagy
GFP tagged LC3 expression vector has recently been
utilized to demonstrate the occurrence of autophagy.
SMMC-7721 and Hep3B cells were seeded (1 × 104 cells/
well) in 96-well plates overnight. GFP-LC3 expressing
plasmids were transiently transfected into cells using the
Fugene HD transfection reagent (Roche, NSW, Australia,
Cat.04709705001) according to the manufacturer’s instruc-
tion. After being cultured for 24 h to ensure expression of
GFP-LC3, the cells were treated with MSC conditioned
medium and cisplatin for 8 h. In a subset of experiments,
3-MA was also added to the cell culture. At the end of
each experiment, autophagy was detected by counting the
number of cells with GFP-LC3-positive dots under fluores-
cence microscope (Olympus IX71). A minimum of 200
cells were counted in each sample. The experiment was
conducted in triplicate.
Electron microscopy
HCC cells were sequentially fixed with 2.5% glutaralde-
hyde acid in 0.1 M PBS buffer (pH 7.4) for 2 h, incubated
in 1% osmium tetroxide in 0.1 M PBS buffer (pH 7.4) for
2–3 h, dehydrated in solutions of ethanol and acetone,
embedded in Araldite, and finally solidified. Sections (50-
60 nm) were cut on a LKB-I ultramicrotome and picked
up on copper grids. After being post-stained with uranyl
acetate and lead citrate, sample sections were observed
with a Philips CM-120 TEM (Philips).
Animal model
All procedures involving animals were performed in ac-
cordance with the institutional animal welfare guidelines
of Second Military Medical University. Subcutaneous
implantation of HCC cells (alone or mixed with MSCs)
was performed in armpit areas of nude mice. Mice were
examined three times per week. Tumor growth was
evaluated by measuring the length and width of the
tumor mass. Animals were sacrificed and tumors wereremoved at the end of the experiment. Tumor masses
were weighed and analyzed by histology.
Enzyme linked immunosorbent assay
ELISA assays were performed with a commercial TGF-
β1 ELISA kit (R&D Systems, Minneapolis, MN). Condi-
tioned medium was collected from wells, aliquoted, and
stored frozen. Assays were performed in duplicate, and
readings were compared with standard curves obtained
with standard protein provided with the kit. Means and
standard deviations of concentrations in triplicate sam-
ples were compared by t-test.
Western blot analysis
Extraction of total soluble proteins from cultivated cells
and western-blot analysis were performed as previously de-
scribed [20]. Primary antibodies used in western blot ana-
lysis were specific for either TGF-β (Abcam, Hongkong,
China, Cat.ab66043) or β-actin (Invitrogen, Cat. AM4302).
Horseradish peroxidase conjugated goat anti-rabbit IgG
was used as the secondary antibody (R&D systerms, Cat.
BAF008).
Short interfering RNA (siRNA) synthesis and transient
transfection
Three siRNA sequences of TGF-β1 were designed using
Oligoengine software and verified by nucleotide BLAST
searches. Three candidate sequences and a control se-
quence with no significant homology were listed in Table 1.
Cells (1-3 × 106) growing to 50%-60% confluence in 10 cm
petri dishes were transfected with siRNA sequences or
their corresponding mock sequences using a Lipofectamine
2000 kit (Invitrogen, Cat.11668-019) with the procedure
provided by the manufacturer. Cells were observed under
a fluorescence microscope and harvested 48 h after
transfection.
Statistical analysis
All data, expressed as mean ± SEM, were from at least
three separate experiments. Data sets were analyzed by
Figure 1 (See legend on next page.)
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Figure 1 Conditioned medium from the culture of inflammatory cytokine-stimulated MSCs enhanced chemoresistance of HCC cells
in vitro. (A) SMMC-7721 cells were treated with cisplatin (20 μM) with conditioned medium collected from MSCs which were pretreated with
inflammatory cytokines or not. The morphology of the cells was captured by microscope. MTT was employed to examine the proliferation of
SMMC-7721 cells, which were treated with cisplatin (20 μM) (B) or epirubicin (0.55 μg/ml) (C) with conditioned medium collected from MSCs
which were pretreated with inflammatory cytokines or not. (D) SMMC-7721 cells were cultured in a 6-well plate with an existence of cisplatin
(20 μM) and the conditioned medium collected from MSCs which were pretreated with inflammatory cytokines or not were added in
SMMC-7721 culture medium for 24 hours. PI/Annexin V-FITC assay was used to measure apoptotic SMMC-7721 cells by flow cytometry. MTT was
employed to examine the proliferation of HepG2 cells, which were treated with cisplatin (20 μM) (E) or epirubicin (0.55 μg/ml) (F) with
conditioned medium collected from MSCs which were pretreated with inflammatory cytokines or not. (*Compared with the group that untreated
with chemotherapy drugs P < 0.05; #Compared with the group that treated with the conditioned medium collected from MSCs which were
pretreated with inflammatory cytokines or not P < 0.05).
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by least significant difference (for comparisons among
multiple groups) or by Student t-test (for comparison
between two groups) using the Microsoft Excel Analysis
Tool Pak (Microsoft, Redmond, WA). P < 0.05 was con-
sidered to be statistically significant.
Results
Inflammatory cytokine-stimulated MSCs enhanced
chemoresistance of hepatocellular carcinoma cells
To study the effect of MSCs on the development of
chemoresistance in HCC cells in inflammatory environ-
ment, we determined influence of chemotherapeutic
agent cisplatin on morphological changes of HCC cell
line-SMMC7721 cells in the presence of different types
of conditioned media from cultures of MSCs. The re-
sults showed that cisplatin effectively inhibited the
growth of SMMC7721 cells. This cisplatin-induced in-
hibition of SMMC7721 cell growth was attenuated when
cells were cultured with conditioned medium from the
culture of MSCs that were pre-stimulated with a combin-
ation of IFN-γ and TNF-α. The development of chemore-
sistance was not observed in SMMC7721 cells when they
were cultured with conditioned medium from the culture
of untreated MSCs or from the culture of MSCs pre-
treated with either IFN-γ or TNF-α alone (Figure 1A).
SMMC7721 cell proliferation was also determined by
MTT assay to verify the development of chemoresistance
in these cells. The results confirmed that conditioned
medium from the culture of MSCs pre-stimulated with
the combination of IFN-γ and TNF-α could effectively im-
prove SMMC7721 cell proliferation in the presence of the
chemotherapeutic agent. In contrast, SMMC7721 cell
proliferation was significantly inhibited by cisplatin or
epirubicin in control groups (Figure 1B and C). Cisplatin
treatment effectively enhanced apoptosis in SMMC7721
cells (Figure 1D). Conditioned medium of MSCs pre-
stimulated with the combination of IFN-γ and TNF-α
caused a significant reduction of cisplatin-induced apop-
tosis in cultured SMMC7721 cells. We also employed the
culture model of HepG2 cells to study chemoresistance in-
duced by MSCs. The results demonstrated that conditionedmedium of MSCs pre-stimulated with the combination
of IFN-γ and TNF-α could effectively protect HepG2
cells from cell toxicity caused by cisplatin or epirubicin
(Figure 1E-F). We further examined the MSCs-induced
chemoresistance in HCC cells in the nude mouse model.
The results showed that MSCs pretreated with the com-
bination of IFN-γ and TNF-α could lead to resistance to
chemotherapy in HCC cells in vivo (Figure 2A and B).
Inflammatory cytokine-stimulated MSCs induced autoph-
agy in hepatocellular carcinoma cells
In previous studies, we have demonstrated that autophagy
contributes to the resistance of HCC cells to chemothera-
peutic agents [21]. We hypothesized that MSCs might in-
duce autophagy of HCC cells in inflammatory environment.
Analysis of autophagy in SMMC7721 cells was performed
using an expression vector encoding GFP-LC3 which is
concentrated in autophagic vacuoles, resulting in punctate
fluorescence within cells undergoing autophagy. As shown
in Figure 3A and B, MSCs pretreated with the combination
of IFN-γ and TNF-α effectively induced autophagy in
SMMC7721 cells, which exhibited a significantly high
number of punctate GFP. In contrast, SMMC7721 cells in
control groups showed primarily diffused fluorescence. In
order to confirm the above observation, we employed
transmission electron microscopy to detect the autophagy
in SMMC7721 cells. The results demonstrated that the
occurrence of autophagy could be observed in SMMC7721
cells when cultured with conditioned medium from the
culture of MSCs pre-stimulated with the combination of
IFN-γ and TNF-α (Figure 3C).
Inhibition of autophagy restored the sensitivity of HCC
cells to chemotherapy
In order to further verify that occurrence of autophagy
in HCC cells lead to enhancement of chemoresistance
in HCC cells, we examined the recurrence of HCC cell
sensitivity to chemotherapy in the presence of autoph-
agy inhibitors. The results showed that the autophagy
inhibitor CQ and 3-MA could effectively restore the
sensitivity of HCC cells to chemotherapeutic agents.
Addition of autophagy inhibitors to the cell culture
Figure 2 Inflammatory cytokine-stimulated MSCs enhanced chemoresistance of HCC cells in vivo. (A) MSCs (1 × 106) were pretreated with
inflammatory cytokines IFN-γ and TNF-α (20 ng/ml each) for 12 hours and then mixed with SMMC-7721 cells (5 × 106) to perform subcutaneous
administration in the nude mice armpit area (five mice for each group). When tumors reached a mean tumor volume of 150 mm3, recipients
were injected in tumor in situ with cisplatin (4 mg/kg) every 3 days. After 27 days of implantation, the animals were sacrificed and tumors were
dissected. (B) The weight of tumor were measured after been removed from the mice. (*Compared with the group that untreated with
chemotherapy drugs P < 0.05; #Compared with the group that MSCs were pretreated with inflammatory cytokines or not P < 0.05).
Figure 3 Conditioned medium from the culture of inflammatory cytokine-stimulated MSCs induced autophagy in HCC cells.
(A) SMMC-7721 cells were transfected with GFP-tagged LC3; after 24 hours transfection, cells were incubated with contidioned medium collected
from MSCs which were pretreated with inflammatory cytokines or not. Images were taken under a fluorescence microscope. Arrows show the
punctate GFP-LC3 in the cytoplasm. (B) The number of punctate GFP-LC3 in each cell of SMMC-7721 was counted and at least 100 cells were
included for each group. The results were shown as means (±SD) (*p < 0.05). (C) Electron micrographs showing the ultrastructure of SMMC-7721
cells with or without conditioned medium collected from MSCs pretreated with inflammatory cytokines or not. Arrows indicate the autophagic
vacuoles in the cytoplasm. Magnification, ×10,000.
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apoptosis in HCC cells following treatment with che-
motherapeutic agents (Figure 4A-D).
Inflammatory cytokines induced overexpression of TGF-β
by MSCs
Several studies have suggested that TGF-β plays an im-
portant role in induction of autophagy [22-24]. Therefore,
we examined TGF-β expression by MSCs in response to
IFN-γ and TNF-α stimulation. As shown in Figure 5,
stimulation with the combination of IFN-γ and TNF-αFigure 4 Inhibition of autophagy restored HCC cell sensitivity to chem
96-well plate with an existence of cisplatin (20 μM) and the conditioned m
cytokines or not were added in SMMC-7721 culture medium for 24 hours.
(10 μM). MTT was employed to examine the proliferation of SMMC-7721 ce
existence of cisplatin (20 μM) and the conditioned medium collected from
added in SMMC-7721 culture medium for 24 hours. The occurrence of auto
V-FITC assay was used to measure apoptotic SMMC-7721 cells ells by flow
96-well plate with an existence of cisplatin (20 μM) and the conditioned m
cytokines or not were added in SMMC-7721 culture medium for 24 hours.
MA (2 mM). MTT was employed to examine the proliferation of SMMC-772
existence of cisplatin (20 μM) and the conditioned medium collected from
added in SMMC-7721 culture medium for 24 hours. The occurrence of auto
V-FITC assay was used to measure apoptotic SMMC-7721 cells ells by flowcaused a significant up-regulation of TGF-β expression at
both mRNA and protein levels in MSCs.
Inhibition of TGF-β expression by MSCs diminished the
ability of MSCs to induce autophagy and chemoresistance
in HCC cells
In order to define the role of TGF-β in MSC-mediated oc-
currence of autophagy and development of chemoresis-
tance in HCC cells, TGF-β expression by MSCs in
response to IFN-γ plus TNF-α stimulation was knock-
down by transfecting MSCs with siRNA against TGF-βotherapy. (A) SMMC-7721 cells (1 × 104/well) were cultured in a
edium collected from MSCs which were pretreated with inflammatory
The occurrence of autophagy was inhibited by autophagy inhibitor-CQ
lls. (B) SMMC-7721 cells were cultured in a 6-well plate with an
MSCs which were pretreated with inflammatory cytokines or not were
phagy was inhibited by autophagy inhibitor-CQ (10 μM). PI/Annexin
cytometry. (C) SMMC-7721 cells (1 × 104/well) were cultured in a
edium collected from MSCs which were pretreated with inflammatory
The occurrence of autophagy was inhibited by autophagy inhibitor-3-
1 cells. (D) SMMC-7721 cells were cultured in a 6-well plate with an
MSCs which were pretreated with inflammatory cytokines or not were
phagy was inhibited by autophagy inhibitor-3-MA (2 mM). PI/Annexin
cytometry. (*P < 0.05).
Figure 5 Inflammatory cytokines induced overexpression of TGF-β by MSCs. MSCs were pretreated with inflammatory cytokines IFN-γ and
TNF-α (20 ng/ml each) for 12 hours. (A) TGF-β mRNA in MSCs was assayed by real-time PCR. (B) The amount of TGF-β1 in conditioned medium
was detected by ELISA. (C) The expression of TGF-β in protein level was examined by western blot. (*P < 0.05).
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knockdown MSCs failed to induce formation of autophagy
in HCC cells (Figure 6A and B). Furthermore, blockade of
TGF-β expression by MSCs diminished the ability of these
MSCs to induce chemoresistance in HCC cells (Figure 6C
and D). These results indicate that up-regulation of TGF-
β expression by MSCs in inflammatory microenvironment
plays a key role in inducing autophagy and development
of chemoresistance in HCC cells.
Discussion
Autophagy is a survival mechanism for both prokaryotic
and eukaryotic cells in the nutrient deficient environ-
ment [25-27]. Energy, amino acids, and other precursor
molecules for maintaining cellular homeostasis and fa-
cilitating cell survival are produced through this process
[28-30]. It has been reported that autophagy associates
with various physiological and pathological processes, in-
cluding differentiation, tumorigenesis, chemoresistance
and adaptation to changed environmental conditions
[31]. The process of autophagy includes three steps: (1)
autophagosome formation, (2) lysosomal fusion with theautophagosome, and (3) lysosomal degradation to pro-
duce precursor molecules, such as amino acids and fatty
acids, to be reutilized for de novo synthesis of macro-
molecules and generation of energy [32]. Autophagy is
activated by hypoxia, starvation and TGF-β1 [21,33,34].
On the other hand, the occurrence of autophagy can be
inhibited not only by the key factor in autophagy associ-
ated signal pathway such as Atg 7 and Beclin 1 but also
by autophagy inhibitor CQ and 3-MA. 3-MA serves as an
inhibitor of phosphatidylinositol 3-kinase, which blocks
autophagosome formation to inhibit autophagy [35]. CQ
is a lysosomotropic drug that impairs autophagic protein
degradation. CQ blocks the last step of the autophagy
pathway, which leads to the accumulation of autophago-
somes [36,37].
MSCs play an important role in the pathogenesis of
various degenerative diseases and immune disorders.
This cell population is a potential target for correcting
aberrant immune reactions. Studies have shown that
MSCs can be induced and expanded ex vivo. These pre-
cursor cells can terminally differentiate into osteoblasts,
chondrocytes, adipocytes, myotubes, neural cells and
Figure 6 Inhibition of TGF-β expression by MSCs diminished the ability of MSCs in inducing autophagy and chemoresistance in HCC
cells. (A) MSCs were transfected with si-TGFβ and then been stimulated by both IFN-γ and TNF-α for 12 hours. The conditioned medium was
collected for further investigation. SMMC-7721 cells were transfected with GFP-tagged LC3; after 24 hours transfection, cells were incubated with
contidioned medium collected from MSCssi-TGFβ. Images were taken under a fluorescence microscope. Arrows show the punctate GFP-LC3 in the
cytoplasm. (B) Electron micrographs showing the ultrastructure of SMMC-7721 cells with or without conditioned medium collected from MSCs
pretreated with inflammatory cytokines or not. Arrows indicate the autophagic vacuoles in the cytoplasm. Magnification, ×10000. (C) SMMC-7721
cells (1 × 104/well) were cultured in a 96-well plate with an existence of cisplatin (20 μM) and the conditioned medium collected from MSCssi-TGFβ
was added in SMMC-7721 culture medium for 24 hours. MTT was employed to examine the proliferation of SMMC-7721 cells. (D) SMMC-7721
cells were cultured in a 6-well plate with an existence of cisplatin (10 μg/mL) and the conditioned medium collected from MSCssi-TGFβ was added
in SMMC-7721 culture medium for 24 hours. PI/Annexin V-FITC assay was used to measure apoptotic SMMC-7721 cells by flow cytometry. (*P < 0.05).
Han et al. Cell & Bioscience 2014, 4:22 Page 9 of 11
http://www.cellandbioscience.com/content/4/1/22hematopoietic supporting stroma [9,10,38]. In previous
studies, we have demonstrated that in tumor inflamma-
tory microenvironment, MSCs may exert immunosup-
pressive function through iNOS to protect tumor cell
from immune surveillance [39]. Furthermore, MSCs
have been shown to promote tumor growth by enhan-
cing tumor angiogenesis via HIF-1α-VEGF signalling
pathway in the colon cancer model [40]. In this study,
we observed that in inflammatory microenvironment,
MSCs could effectively induce chemoresistance in HCC
cell line cells.
In previous studies, we have demonstrated that autoph-
agy decreases the sensitivity of hepatoma cells to chemo-
therapeutic agents by affecting their apoptotic potential
[21]. In addition, we have shown that autophagy activated
by hypoxia mediates the tolerance of hepatocellular car-
cinoma cells to nutrient deprivation, which is dependent
on the activity of Beclin 1 [41]. In this study, we found that
MSC-induced chemoresistance in HCC cell line cells was
associated with the occurrence of autophagy, a protective
mechanism of HCC cells to resist chemotherapeutic
agents. Stimulation with the combination of IFN-γ and
TNF-α could provoke TGF-β expression by MSCs. Theenhancement of chemoresistance in HCC cell line cells
was in a TGF-β dependent manner. Our results suggest
that overexpression of TGF-β by MSCs in the HCC in-
flammatory microenviroment may favor the development
of chemoresistance in HCC cells by inducing autophagy.
TGF-β plays an important role in regulating cell growth,
differentiation and migration. TGF-β has been reported to
induce autophagy in normal bovine mammary epithelial
BME-UV1 cells [12]. Furthermore, TGF-β also induced
autophagy not only in some mammary carcinoma cells
but also in human hepatocellular carcinoma cells. Accu-
mulation of autophagosomes and conversion of LC3 from
type1 to type2 induced by TGF-β results in degradation of
long-lived proteins. TGF-β upregulates the expression of
ATG5, ATG7, BECLIN1, and death-associated protein
kinase (DAPK) in mRNA level [6]. Recently, Roodhart and
colleagues have reported that endogenous MSCs become
activated during treatment with platinum analogs and se-
crete factors which protect tumor cells against a range of
chemotherapeutic agents [42]. Our results reveal another
important fact that tumor inflammatory microenviron-
ment is a key player in activating MSCs to induce che-
moresistance of HCC cells. Inflammation is a fundamental
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oma, which exists not only within the tumor tissue but also
in tissues surrounding the tumor. MSCs in inflammatory
microenvironment may persistently promote the deve-
lopment of chemoresistance in HCC cells during tumor
growth. One mechanism underlying MSC-promoted de-
velopment of chemoresistance in HCC cells is via their
overexpression of TGF-β in response to inflammatory
stimuli in the tumor microenvironment. Inhibition of MSC
activation in the inflammatory microenvironment may
serves as a potential approach to improve chemosensitivity
of HCC cells.
Conclusions
Taken together, these results suggest that increase in
TGF-β expression by MSCs in the inflammatory micro-
environment of HCC promotes the development of che-
moresistance in HCC cells.
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